Abstract:Abstract Study question We aimed to investigate whether serum Progesterone (P) on the day of hCG trigger can be used as a biomarker to predict the IVF/ICSI outcomes in PCOS patients. Summary answer PCOS patients got better IVF/ICSI outcomes with “higher” progesterone level (2.7-5.9mmol/L). What is known already There were several studies suggesting serum Progesterone (P) on the day of hCG trigger can be used as a biomarker to predict IVF outcomes, and to decide fresh cycle embryo transfer or frozen all. But there was few study focus on PCOS patients. Study design, size, duration This is a single-center retrospective cohort study in PCOS women undergoing the first transfer of an IVF cycle between January 1st 2010 and December 31th 2019. There were 141,539 oocyte retrieval cycles during the study period, and 97,189 cycles were their first IVF cycle. PCOS was diagnosed according to the Rotterdam criteria. Among them, 3,146 cycles full filled the inclusion and exclusion criteria, and all with two embryos transferred on Day 3. Participants/materials, setting, methods We compared the live birth rate of fresh embryo transfer, stratified for serum P level. We looked for interaction between serum P level and live birth rate of fresh cycles. The serum P level within normal range (< 6nmol/L) on the day of hCG trigger day was divided into 4 quartiles. The four quartiles were defined as ≤ 1.35 nmol/L (Q1), >1.35-1.93 nmol/L (Q2), >1.93-2.7 nmol/L (Q3), >2.7 nmol/L (Q4). Main results and the role of chance The baseline characteristics with no different between groups, except BMI. The patients in Q4 group with lowest BMI, significantly higher number of oocytes retrieved and live birth rate (P < 0.05) . The Logistic regression analysis of the relative factors on live birth rate including BMI, basal LH and number of oocytes retrieved [P = 0.003, 0.030, 0.037 respectively, 95%CI (1.022, 1.111), (1.004, 1.076), (1.002, 1.082)]. Limitations, reasons for caution Due to the retrospective nature of this study, a well-designed and matched large sample prospective study is needed. The definition of elevated P level and the method of hormonal assessments were different between studies, this limiting the comprehensive analysis of researches and the further verification of existing results. Wider implications of the findings PCOS patients who with normal range P level on hCG day, got better IVF/ICSI outcomes with “higher” progesterone level (2.7-5.9mmol/L). Weight control is important for PCOS patients accepting IVF treatment. Trial registration number NOT APPLICABLE

Progesterone Levels On Oocyte Retrieval Day Can Predict The Quantity Of Viable Embryos But Not Pregnancy Outcome Of Intracytoplasmic Sperm Injection

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

Serum Progesterone Levels on the Day of Oocyte Retrieval and the Quantity of Viable Embryos/Pregnancy Outcomes during ICSI Cycles

The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium.

Recurrent Ivf Failure Is Associated With Elevated Progesterone On The Day Of Hcg Administration

Comparison of Progesterone Measurement on Day Of, and Day After, HCG Administration in IVF–embryo Transfer Cycles

Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer?

Association of the serum progesterone level on the day of HCG injection and the outcome of in vitro fertilization and embryo transfer

High progesterone levels on the day after HCG injection has no effect on clinical pregnancy outcomes in in vitro fertilization-embryo transfer

P-583 PCOS Patients Got Better IVF/ICSI Outcomes with “higher” Progesterone Level on Hcg Day: a Retrospective Study of Ten Years Data

Effects of high progesterone on outcomes of in vitro fertilization-embryo transfer in patients with different ovarian responses.

Premature progesterone elevation does not alter oocyte quality in in vitro fertilization

Premature Progesterone Rise Positively Correlates with Clinical Pregnancy Rate in In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) Patients with good Ovarian Response

Impact of progesterone level after HCG administration on the outcome of IVF in long GnRH-agonist pituitary suppression protocol

Effect of serum estradiol and progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in pregnancy outcome of in vitro fertilization-embryo transplantation

Serum Steroid Metabolome on the Day of Oocyte Retrieval in Women with Polycystic Ovarian Syndrome and Its Association with Pregnancy Outcome of in Vitro Fertilization.

Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles

Adverse Impact of Elevated Progesterone Levels on Human Chorionic Gonadotropin Trigger Day on Blastocyst Transfer Outcomes in Gonadotropin-Releasing Hormone Agonist Cycles.

Serum Progesterone Concentration on Day of HCG Administration and IVF Outcome

The late-follicular-phase progesterone to retrieved oocytes ratio in normal ovarian responders treated with an antagonist protocol can be used as an index for selecting an embryo transfer strategy and predicting the success rate: a retrospective large-scale study

Impact of Progesterone Level of Late Follicular Phase on Outcome of in Vitro Fertilization